Scarica l'app Stockscreener
4.79
0.83%
-0.04
Dopo l'orario di chiusura:
4.67
-0.12
-2.51%
Optimi Health Corp Borsa (OPTH) Ultime notizie
SRx Health Decided To Invest In A Psychedelic Drug Company That Just Went Public – Here’s What Aided The Decision - Stocktwits
Top Optimi Health (OPTH) Competitors 2026 - MarketBeat
Optimi Health (OPTH) Stock Chart and Price History 2026 - marketbeat.com
Optimi Health Sets Up US$100 Million Equity Line for Psychedelic Drug Expansion - TipRanks
Optimi Health (OPTH) secures US$100M equity line with convertible note sweeteners - Stock Titan
Optimi Health Corp. Establishes US$100 Million Discretionary Equity Line of Credit with Seven Knots - kalkine.ca
Optimi Health (OPTH) raises $20.7M, posts larger loss and builds cash buffer - Stock Titan
Optimi Health Corp. Announces Up to US$100 Million Equity Line of Credit with Seven Knots - Quiver Quantitative
Optimi Health Establishes Discretionary Equity Facility - Yahoo Finance
Optimi Health Corp. Common Shares (NASDAQ: OPTH) Stock Price, News & Analysis - kalkine.com.au
Optimi Health Corp. announced that it expects to receive $101.5 million in funding from Seven Knots, LLC - marketscreener.com
Optimi Health Stock Slides 3.4% on August 11 — Is This Psychedelics Manufacturer Getting Interesting Again? - kalkine.ca
Optimi Health Corp (CN:OPTI) Shares Under Pressure as Psychedelic Market Uncertainty and Development Risks Weigh on Sentiment - kalkine.ca
Optimi Health Corp. (OPTH) investor reports 8.25% beneficial stake via Cathay Visions - Stock Titan
Optimi Health CEO Dane Stevens holds 456,347 shares after indirect purchase at CDN$ 6.7 - Bitget
Optimi Health (OPTH) CEO adds 3,800 shares at CDN$6.70 - Stock Titan
CSE Filings for Optimi Health Corp. - The Canadian Securities Exchange (CSE)
Optimi Health Corp. Revenue Breakdown – CSE:OPTI - TradingView
Optimi Health Corp. (OPTH) - Zacks Investment Research
Optimi Health Corp. (OPTH) Cash From Operations (Quarterly) - Zacks Investment Research
Optimi Health (OPTH) seeks approval for equity plan and new preferred shares - Stock Titan
Optimi Health Corp. Revenue Breakdown – BOATS:OPTH - TradingView
Optimi Health Corp. Revenue Breakdown – NASDAQ:OPTH - TradingView
Optimi Health to Enter Asian Market with PsiloThai Collaboration on Psilocybin Research - TMX Newsfile
OPTH|Optimi Health Ord Shs|Price:4.680|Chg%:-0.070 - TradingKey
Optimi Health (OPTH) CEO boosts stake with 18,700-share buy - Stock Titan
Optimi Health (OPTH) 10K Form and Latest SEC Filings 2026 - MarketBeat
Red Light Holland Announces Corporate Rebrand to Rhelion Life Sciences Corp - Yahoo! Finance Canada
Optimi Health Completes First 2026 Production of MDMA and Psilocybin Capsules - TMX Newsfile
3 Psychedelic Stocks With Potential Clinical Trial Catalysts - Sahm
OPTH Price Today: Optimi Health Corp. Stock Price, Quote & Chart - mexc.co
Optimi Health Completes Commercial Psilocybin Production to Address Treatment-Resistant Depression in Australia - AOL.com
Optimi Health Announces Pricing of Oversubscribed US$15 Million Public Offering and Nasdaq Uplisting - AOL.com
Optimi Health (OPTH) Stock Analysis Report | Financials & Insights - Benzinga
Optimi Health Corp. - The Canadian Securities Exchange (CSE)
Optimi Health Corp. (OPTH) Stock: Surges 8% as Psilocybin Shipments to Australia Signal Growing Commercial Momentum - parameter.io
Optimi Health completes psilocybin export to Australia for patients with treatment-resistant depression - MSN
Optimi Health Completes Psilocybin Export to Australia for Patients With Treatment-Resistant Depression - Financial Times
Optimi Health (NASDAQ: OPTH) makes third psilocybin shipment for TRD - Stock Titan
Optimi Health Completes Psilocybin Export to Australia for Patients With Treatment-Resistant Depression - GlobeNewswire Inc.
Price to earnings forward of Optimi Health Corp. – CSE:OPTI - TradingView
Price to sales forward of Optimi Health Corp. – LSX:A411WC - TradingView
Optimi Health Corp. (OPTH) Cash From Operations (TTM) - Zacks Investment Research
Optimi Health Corp. (OPTH) Market Cap - Zacks Investment Research
Optimi Health (OPTH) Stock Trends and Sentiment 2026 - MarketBeat
OPTH|Optimi Health Ord Shs|Price:4.060|Chg%:0.05 - TradingKey
Price to book ratio of Optimi Health Corp. – TRADEGATE:8BN0 - TradingView
Optimi Health Corp. (OPTH) Book Value - Zacks Investment Research
Optimi Health Corp. (OPTH) Earnings Yield (TTM) - Zacks Investment Research
Optimi Health Corp. (OPTH) Price To Free Cash Flow - Zacks Investment Research
Optimi Health Corp. (OPTH) Revenue (Quarterly) Yoy Growth - Zacks Investment Research
Optimi Health Corp. (OPTH) Free Cash Flow (TTM) - Zacks Investment Research
Optimi Health Corp. (OPTH) Total Expenses (TTM) - Zacks Investment Research
0.79%
5.15%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):